Chronic Pain | MedlinePlus
Chronic pain lasts longer than three months or the time in which you should have healed. It is not always curable, but treatments can help.
Related Articles
Trump signs order in bid to boost pharma manufacturing in the U.S.
Federal agencies, including the FDA and the EPA, were ordered to accelerate approval of domestic manufacturing plants.
PSMA-PET for Overall Survival Outcomes Risk Stratification of Prostate Cancer “Presentation” – Wolfgang Fendler
At the 2025 UCSF-UCLA PSMA Conference, Wolfgang Fendler demonstrates how PSMA-PET provides spatial biomarkers predicting overall survival in prostate cancer. Drawing from the 10,000+ patient…
Impact of Clinical Guidelines on PSMA-PET Implementation “Presentation” – Emmanuel Antonarakis
At the 2025 UCSF-UCLA PSMA Conference, EmmanuelAntonarakis reviews US guidelines for PSMA-PET in prostate cancer from NCCN, SNMMI, and AUA/SUO. He notes consensus on use…
An Overview of Treatment Strategies in Localized Prostate Cancer: From Active Surveillance to Intensive Therapy – Neal Shore
Program: State-of-the-Art Interdisciplinary Management of Prostate Cancer This series is part of an Independent Medical Education Initiative Supported by BAYER U.S. LLC PHARMACEUTICALS Biographies: Neal…
Behavioral Health Research and Policy Should Engage People With Disabilities
More than 70 million U.S. adults live with physical, sensory, cognitive, developmental, or intellectual disabilities. These individuals are more than twice as likely than other…
Pharmalittle: We’re reading about FDA rehiring PDUFA staff, pharma and Medicaid prices, and more
The FDA is asking some of its recently fired staff responsible for critically important funding negotiations with drugmakers to return
Pharmalittle: We’re reading about FDA rehiring PDUFA staff, pharma and Medicaid prices, and more
The FDA is asking some of its recently fired staff responsible for critically important funding negotiations with drugmakers to return
Advances and Challenges in High-Risk CSPC: A Multidisciplinary Approach to Patient Management – Paul Sieber
Program: State-of-the-Art Interdisciplinary Management of Prostate Cancer This series is part of an Independent Medical Education Initiative Supported by BAYER U.S. LLC PHARMACEUTICALS Biographies: Paul…
So What’s the Deal with ICHRA? – MedCity News
The number of US employees offered ICHRAs continues to grow. Yet, headwinds – including competition, individual coverage market uncertainty, and complexity – may hamper the…
PSMA PET Imaging and Targeted Therapies: A Case Study on High-Risk Localized Prostate Cancer – Tian Zhang
Program: State-of-the-Art Interdisciplinary Management of Prostate Cancer This series is part of an Independent Medical Education Initiative Supported by BAYER U.S. LLC PHARMACEUTICALS Biographies: Tian…